Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors

Hans G. Beger MD, FACS, Emeritus Professor of Surgery, Universitätsklinikum Ulm, Universität Ulm, Ulm, Germany.Akimasa Nakao MD, PhD, FACS, Professor Emeritus, Nagoya University; President, Nagoya Central Hospital, Nagoya, Japan.John P. Neoptolemos MA, MB, BChir, MD, FRCS, FMedSci, The Owen and Ellen Evans Chair of Surgery; NIHR Senior Investigator; NIHR Liverpool Pancreas Biomedical Research Unit, The Liverpool Clinical Trials Unit and Cancer Research UK; Cancer Trials Unit Director, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.Shu You Peng MD, FACS, FRCSG, ESA, Professor, Department of Surgery, Second Affi liated Hospital, Zhejiang University, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.Michael G. Sarr MD, J.C. Masson Professor of Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.

• Section 1: Ductal Adenocarcinoma of the Pancreas1. Histologic Classification and Tumor Staging of Pancreatic CancerAkio Yanagisawa and Eiichi Konishi2. What We Know about Carcinogenesis of Ductal Adenocarcinoma of the PancreasC. J. Bruns, H. Niess, B. Schwarz, A. Kleespies, M. K. Angele and K.-W. Jauch3. Familiar Cancer of the PancreasDetlef K. Bartsch, Volker Fendrich and Peter Langer4. Clinical, Laboratory and Radiologic Presentation of Pancreatic CancerSusumu Hijioka and Kenji Yamao5. Standards of Oncologic Pancreatic SurgeryZhi Ven Fong and Keith D. Lillemoe6. Extended Resection for Pancreatic Cancer: Risk and BenefitsAkimasa Nakao7. Risk/Benefit of Total Pancreatectomy for Pancreatic Cancer: Are There Indications?Ake Andrén-Sandberg and Ralf Segersvard8. Is There a Benefit for Additional Arterial Resection of Ductal Cancer of the Pancreas?Satoshi Hirano and Takahiro Tsuchikawa9. Who Benefits from Ultra-Radical Pancreatic Cancer Extirpation?Akimasa Nakao10. Risk and Results of Pancreatic Cancer ResectionNorbert Hüser, Volker Assfalg and Helmut Friess11. Pancreatic Cancer: The Role of Bypass ProceduresJ.A.M.G. Tol, O.R.C. Busch, T.M. van Gulik and D.J. Gouma12. Evidence of Adjuvant Chemotherapy of Ductal Pancreatic CancerAsma Sultana, Christopher Halloran, Daniel Palmer, Paula Ghaneh Trevor Cox and John P Neoptolemos13. Neoadjuvant Chemo- and Radio-Chemotherapy: Is There a Survival Advantage for Pancreatic Cancer PatientsSusan Tsai, Ben George, Kathleen K. Christians and Douglas B. Evans14. Standards of Palliative Chemotherapy and Chemoradiotherapy of Local Advanced Pancreatic Cancer, Side Effects and Survival BenefitsHana Algül and Roland M. Schmid15. Management of Local and Distant Recurrence after Pancreatic Cancer ResectionTakuji Okusaka, Kenji Hashimoto, Tomoko Katsui Taniyama, Hideki Ueno, Chigusa Morizane, Shunsuke Kondo, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi and Masafumi Ikeda16. Survival 3-, 5- and 10-years after Adjuvant Regional and Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer Patients: an Institutional ExperienceOsamu Ishikawa, Hiroaki Ohhigashi and Hidenori Takahashi17. Non-ductal Primary Malignancies of the Pancreas: Acinus Cell CarcinomaMarius Distler and Robert Grutzmann18.Non-ductal Primary Malignancies of the Pancreas: Metastatic MalignanciesVictor Zaydfudim, Michael B. Farnell and Michael G. SarrSection 2: Periampullary Cancers19. Histopathology of Tumor of the Ampulla of VaterLi-rong Chen20. Clinics of Periampulary CancerCai Xiujun21. Adenoma of the Papilla of Vater and Endoscopic ManagementTakao Itoi and Shujiro Tsuji22. Controversies about Local or Regional Treatment of Adenoma of the Papilla of Vater: Japanese ExperienceTakehiro Ota, Masakazu Yamamoto and Ken Takasaki23. Cancer of the Papilla: Surgical ManagementHans G. Beger Q L Qiao and B Poch24. Evidence of Surgical Management of Distal Common Bile Duct CancerYingbin Liu and Wenguang Wu25. Evidence of Surgical Management of Duodenum CancerRory L. Smoot and Florencia G. Que26. Survival and Chance of Cure after Surgery, Adjuvant and Palliative Chemotherapy of Periampullary TumorsHao ran Qian and Shu You PengSection 3: Cystic Neoplastic Lesion of the Pancreas27. Histologic Classification and Staging of Cystic Neoplastic Lesions of the PancreasRondell Graham and Tom Smyrk28. Clinical Presentation of Cystic Neoplasms of the PancreasMasao Tanaka29. EUS and Cystic Fluid Analysis of the Pancreas: Evidence of Diagnostic MeasuresWon Jae Yoon and William R. Brugge30. Natural History of IPMN: Adenoma/Carcinoma Sequence in IPMNMasanori Sugiyama and Yutaka Suzuki31. What are the Pathologic Criteria that Justified Observational Management in Patients with Cystic Naoplastic Lesions of the Pancreas?Klaus Sahora, and Carlos Fernández-del Castillo32. Indication for Operative Intervention of Cystic Neoplasms of the PancreasGeorge H. Sakorafas and Vassileios Smyrniotis33. Surgical Management of IPMN Lesions of the PancreasMarcus C.B. Tan and Peter J. Allen34. Surgical Management of MCN Lesions of the PancreasKlaus Sahora and Carlos Fernández-del Castillo35. Surgical Management of SCA of the PancreasGiuseppe Malleo, Claudio Bassi and Roberto Salvia36. Surgical Management of SPsN of the PancreasSong Cheol Kim37. Limited Oncologic Resection or Major Surgery of Cystic Neoplasms of the Pancreas?Hans G Beger, Yang Yinmo, and Akimasa Nakao38. Enucleation of Cystic Neaplasia of the Pancreas?Janak A. Parikh and C. Max Schmidt39. Long-Term Outcome after Observation and Surgical Treatment of the Cystic Neoplasms of the PancreasGiuseppe Malleo, Roberto Salvia and Claudio BassiSection IV: Endocrine Neoplasms of the Pancreas40. Classification of Endocrine Tumors of the PancreasJ. J. Mukherjee and K. O. Lee41. Clinical Manifestation of Endocrine Tumors of the PancreasK. O. Lee42. Evidence of Hormonal, Laboratory, Bio-Chemistric and Instrumental Diagnostics of Endocrine Tumors of the PancreasC.E.D.Ng, J. J. Mukherjee and K.O. Lee43. Evidence of Medical and Radionucleotide Treatment of Endocrine Tumors of the PancreasDavid C.E. Ng., J. J. Mukherjee and K.O. Lee44. Insulinoma: Evidence of Surgical TreatmentY. P. Mou45. Gastrinoma: Evidence of Surgical TreatmentR. Y. Qin46. Rare Endocrine Tumors of the Pancreas: Evidence of ManagementJiang Tao Li, Shu You Peng and De Fei Hong47. Long-term Outcome after Clinical Management of Endocrine Tumors of the PancreasBin Xu and Jian Wei WangSection V: Chronic Pancreatitis with Inflammatory Tumor of the Pancreas48. Chronic Pancreatitis with Inflammatory Mass in the Pancreatic HeadUlrich F. Wellner and Tobias Keck49. Chronic Tropical Pancreatitis: Clinical syndromes, natural course management principlesSavio G. Barreto and Shailesh V. Shrikhande50. Laboratory, Endoscopic and Radiologic Diagnostic of Chronic Pancreatitis with Inflammatory Mass in the HeadJ. Enrique Domínguez-Munoz, Julio Iglesias-Garcia and José Larino-Noia51. Autoimmune Pancreatitis : How to Recognize this Entity and Avoid Surgical TreatmentRaghuwansh P. Sah and Suresh T. Chari52. What is the Place of Interventional-Endoscopic Treatment in Chronic Pancreatitis/Inflammatory Tumor of the Pancreatic Head?Yoshiki Hirooka and Hidemi Goto53. When to Change from Conservative to Surgical Management in Alcoholic Chronic and Tropical Chronic PancreatitisShailesh V. Shrikhande and Savio G. Barreto54. Duodenum Preserving Pancreatic Head Resection of Chronic Pancreatits with Inflammatory MassHans G. Beger and Qiao Qilu55. Major Resection for Chronic PancreatitisJohn C. McAuliffe and John D. Christein56. Short-term and Long-term Outcome after Interventional and Surgical Treatment of Chronic Pancreatitis with Inflammatory MassVolker Assfalg, Norbert Hüser and Helmut Friess